Inactive Instrument

Press Releases VIVUS, Inc.

Equities

VVUSQ

US9285513084

Pharmaceuticals

Press Releases

20-12-14	VIVUS : Receives Court Approval of Joint Chapter 11 Plan of Reorganization	AQ
20-11-16	VIVUS : Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date	AQ
20-11-16	VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20-07-13	VIVUS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure (form 8-K)	AQ
20-07-07	VIVUS INC : Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
20-07-07	VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Wholly Owned Subsidiary of IEH Biopharma LLC	GL
20-06-19	VIVUS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
20-06-02	VIVUS INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
20-06-02	VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.	GL
20-05-08	VIVUS INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	AQ
20-05-07	Vivus: 1Q Earnings Snapshot	AQ
20-05-06	VIVUS INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	AQ
20-05-06	VIVUS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
20-05-06	VIVUS Reports First Quarter 2020 Financial Results	GL
20-05-04	VIVUS : to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020	AQ
20-05-04	VIVUS : Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt	AQ
20-05-01	VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020	GL
20-05-01	VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt	GL
20-05-01	VIVUS INC : Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20-04-03	VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20-04-03	VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	GL
20-04-03	VitalTech : Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules	PR
20-04-02	VIVUS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20-04-01	VIVUS : Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	AQ
20-04-01	VIVUS : Accelerates the Launch of Telemedicine and Remote Monitoring Modules to Facilitate Effective Patient Care during 'Social Distancing'	AQ